FindTrial
Sign In

Role of iron stores in Polycystic ovarian syndrome patients undergoing Infertility treatment

Role of Serum Ferritin in Polycyctic ovarian syndrome and Non Polycystic ovarian syndrome in Assisted Reproductive Technology Cycles

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050464
Enrollment
75
Registered
2023-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing ART treatment using Antagonist protocol

Exclusion criteria

Exclusion criteria: 1.Patients undergoing ART treatment using flare protocol 2. PCOS with other ovarian pathology 3. AMH less than or equal to 1.5 ng/ml 4. Premature Ovarian Failure 5. Donor Oocyte ART cycles

Design outcomes

Primary

MeasureTime frame
Primary outcome- Serum ferritin levels in PCOS and non PCOS patients undergoing ART treatment. Timepoint: On the day of start of recruitment of IVF—

Secondary

MeasureTime frame
Secondary outcome- 1)Oocyte number and quality 2)Grade of embryo 3)The relation between Serum ferritin levels and Follicular ferritin levelsTimepoint: 1)On the day of oocyte retrival,that is 10-12 days from the start of IVF 2)3-5 days after oocyte retrieval 3)Day of start of IVF and day of oocyte retrieval—

Countries

India

Contacts

Public ContactDhanya V

KMC MANIPAL

prashanth.adiga@manipal.edu9035036832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026